Cite

    Colombe Saillard et al.. “Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.” Leukemia & lymphoma, vol. 57, no. 3, n.d., pp. 714–716. http://access.bl.uk/ark:/81055/vdc_100034281744.0x000036